AIG
HBIO icon

American International Group’s Harvard Bioscience HBIO Stock Holding History

American International Group’s Portfolio HBIO Stock Details HBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,998
Closed -$84.7K – 1159
2024
Q1 		$84.7K Sell
1,998
-17
-0.8% -$764 ﹤0.01% 2606
2023
Q4 		$108K Buy
2,015
+15
+0.8% +$677 ﹤0.01% 2521
2023
Q3 		$86K Buy
2,000
+117
+6% +$5.4K ﹤0.01% 2585
2023
Q2 		$103K Buy
+1,883
New +$103K ﹤0.01% 2556
2022
Q2 		– Sell
-1,951
Closed -$121K – 3167
2022
Q1 		$121K Sell
1,951
-137
-7% -$8.1K ﹤0.01% 2514
2021
Q4 		$147K Sell
2,088
-62
-3% -$4.41K ﹤0.01% 2538
2021
Q3 		$150K Sell
2,150
-8
-0.4% -$637 ﹤0.01% 2595
2021
Q2 		$180 Sell
2,158
-73
-3% -$5.16K ﹤0.01% 2568
2021
Q1 		$122 Buy
2,231
+6
+0.3% +$292 ﹤0.01% 2610
2020
Q4 		$95 Sell
2,225
-64
-3% -$2.39K ﹤0.01% 2684
2020
Q3 		$69K Sell
2,289
-18
-0.8% -$605 ﹤0.01% 2732
2020
Q2 		$72K Buy
+2,307
New +$62.2K ﹤0.01% 2721
2019
Q2 		– Sell
-2,322
Closed -$100K – 3129
2019
Q1 		$100K Sell
2,322
-75
-3% -$2.72K ﹤0.01% 2621
2018
Q4 		$76K Buy
2,397
+28
+1% +$1.1K ﹤0.01% 2728
2018
Q3 		$124K Buy
2,369
+80
+3% +$4.49K ﹤0.01% 2711
2018
Q2 		$122K Buy
+2,289
New +$117K ﹤0.01% 2670
2016
Q2 		– Sell
-1,959
Closed -$59K – 3638
2016
Q1 		$59K Hold
1,959
– – ﹤0.01% 3775
2015
Q4 		$68K Sell
1,959
-4
-0.2% -$137 ﹤0.01% 3735
2015
Q3 		$74K Buy
1,963
+3
+0.2% +$140 ﹤0.01% 3718
2015
Q2 		$112K Buy
+1,960
New +$112K ﹤0.01% 3595
2014
Q2 		– Sell
-1,734
Closed -$82.2K – 4992
2014
Q1 		$82.2K Buy
1,734
+41
+2% +$1.87K ﹤0.01% 3570
2013
Q4 		$79.6K Sell
1,693
-562
-25% -$24.5K ﹤0.01% 3518
2013
Q3 		$89.9K Buy
2,255
+5
+0.2% +$197 ﹤0.01% 3399
2013
Q2 		$80.7K Buy
+2,250
New +$86.1K ﹤0.01% 3297

Other funds holding HBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
2C
272 Capital Dallas, Texas $40M AUM 150.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

American International Group's HBIO Position: Q2 2024 in Review

American International Group sold out of Harvard Bioscience (HBIO) in Q2 2024, closing a stake of 1,998 shares — an estimated $84.7K sold.

American International Group first reported a position in HBIO in Q2 2013 and held it in 24 quarters. The position peaked at $150K in Q3 2021. 100 funds tracked by Wall St. Rank hold HBIO as of Q2 2024.

  • American International Group reported no remaining Harvard Bioscience position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 1,998 Harvard Bioscience shares in Q2 2024, an estimated $84.7K.
  • American International Group first reported a position in Harvard Bioscience in Q2 2013 and held it in 24 quarters.
  • American International Group's Harvard Bioscience position peaked at $150K in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Harvard Bioscience as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.